Stock Events

Stock Events

Medical Developments International 

$0.37
12
+$0.07+22% Monday 20:00

Statistics

Day High
0.3
Day Low
0.3
52W High
0.51
52W Low
0.3
Volume
173
Avg. Volume
141
Mkt Cap
41.76M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Apr 20
$0.01
Oct 19
$0.01
Apr 19
$0.01
Oct 18
$0.01
Apr 18
$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

18FebExpected
Q2 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.34
-0.23
-0.11
0
Expected EPS
-0.013258253143716826
Actual EPS
-0.001894036163388118

Financials

0.22%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
50.59MRevenue
111,746.48Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MDDVF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceuticals sector, directly competing in various healthcare markets including pain management, where Medical Developments International is active with its non-opioid pain relief product.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes in the development and marketing of medications and vaccines for a wide range of conditions, including those in pain management, a key area for Medical Developments International.
Novartis
NVS
Mkt Cap237.61B
Novartis is a multinational pharmaceutical company that produces drugs in many of the same therapeutic areas as Medical Developments International, including analgesics for pain management.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in the pharmaceuticals industry, focusing on areas including chronic pain management, where it competes with Medical Developments International's offerings.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a global healthcare company that develops and markets drugs and vaccines, including for pain relief, making it a competitor in the same market as Medical Developments International.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is involved in the development, manufacturing, and marketing of drugs across various therapeutic areas, including pain management, competing with Medical Developments International.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a global company that manufactures generic and specialty medicines, including pain management solutions, competing with Medical Developments International's products.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company that develops medicines in several therapeutic areas, including pain, directly competing with Medical Developments International.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global pharmaceutical company that offers a broad range of medicines, including those for pain management, competing with Medical Developments International.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that operates in many of the same therapeutic areas as Medical Developments International, including pain management.

About

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease; Penthrox, a trauma and emergency pain relief product; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, oxygen resuscitation kits, oxygen therapy masks, and resuscitators. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.
Show more...
CEO
Mr. Brent MacGregor
Country
AU
ISIN
AU000000MVP2

Listings

AU
AU
MVP.AU
OTC Link
US
MDDVF

0 Comments

Share your thoughts

FAQ

What is Medical Developments International stock price today?▼
The current price of MDDVF is $0.37 USD — it has increased by +22% in the past 24 hours. Watch Medical Developments International stock price performance more closely on the chart.
What is Medical Developments International stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medical Developments International stocks are traded under the ticker MDDVF.
What is Medical Developments International market cap?▼
Today Medical Developments International has the market capitalization of 41.76M
When is the next Medical Developments International earnings date?▼
Medical Developments International is going to release the next earnings report on August 20, 2026.
What were Medical Developments International earnings last quarter?▼
MDDVF earnings for the last quarter are -0 USD per share, whereas the estimation was -0.01 USD resulting in a +85.71% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Medical Developments International revenue for the last year?▼
Medical Developments International revenue for the last year amounts to 50.59M USD.
What is Medical Developments International net income for the last year?▼
MDDVF net income for the last year is 111,746.48 USD.
Does Medical Developments International pay dividends?▼
Yes, MDDVF dividends are paid annual. The last dividend per share was 0.01 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Medical Developments International located?▼
Medical Developments International operates in the Health Care sector.
When did Medical Developments International complete a stock split?▼
Medical Developments International has not had any recent stock splits.
Where is Medical Developments International headquartered?▼
Medical Developments International is headquartered in Scoresby, AU.